Physician profile
Amy Beth Stein
NPI 1952336141
$4,498.73
in general payments reported to CMS, 2019-2025
16 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $337 · 2021: $671 · 2022: $1,211 · 2023: $618 · 2024: $313 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $710.29 | 2019-2024 | Cequa |
| Oyster Point Pharma, INC. | $581.37 | 2022-2024 | Tyrvaya, Ryzumvi, Ryzumvi |
| Bausch & Lomb Americas INC. | $577.38 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $572.87 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $421.20 | 2021-2022 | |
| Shire North American Group INC | $368.20 | 2019 | |
| Novartis Pharmaceuticals Corporation | $329.89 | 2019-2022 | |
| Abbvie INC. | $293.77 | 2022 | |
| Glaukos Corporation | $188.29 | 2023 | |
| Allergan, INC. | $168.65 | 2020-2022 | |
| Alcon Vision LLC | $83.18 | 2023-2025 | Eysuvis, Rocklatan, Tryptyr |
| Sight Sciences, INC. | $58.41 | 2022 | |
| Dompe US, INC. | $52.65 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $34.13 | 2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $33.49 | 2021-2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $24.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.